Equillium (STU:0FY) Long-Term Capital Lease Obligation : €0.27 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Equillium Long-Term Capital Lease Obligation?

Equillium's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.27 Mil.

Equillium's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€0.47 Mil) to Dec. 2023 (€0.35 Mil) and declined from Dec. 2023 (€0.35 Mil) to Mar. 2024 (€0.27 Mil).

Equillium's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€1.09 Mil) to Dec. 2022 (€0.78 Mil) and declined from Dec. 2022 (€0.78 Mil) to Dec. 2023 (€0.35 Mil).

Equillium Long-Term Capital Lease Obligation Historical Data

The historical data trend for Equillium's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equillium Long-Term Capital Lease Obligation Chart

Equillium Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.09

0.78

0.35

Equillium Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.67	0.56	0.47	0.35	0.27

Equillium (STU:0FY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Equillium Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Equillium's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Equillium (STU:0FY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Equillium Inc (STU:0FY) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

EQ:USA

Address

2223 Avenida De La Playa, Suite 105, La Jolla, CA, USA, 92037

Website

https://www.equilliumbio.com

Equillium Inc is a biotechnology developing therapies to treat autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph 2 ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.

Equillium (STU:0FY) Headlines

No Headlines